Alliance Pharma Share Price | |
---|---|
Price | 33.10 |
Bid | 32.95 |
Ask | 33.85 |
Change | -0.60 (-1.78%) |
Volume | 1,864,058 |
Open | 33.95 |
High | 33.95 |
Low | 32.95 |
Prev. Close | 33.70 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £178.87m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 32.95 |
52 Week Low Date | 03-May-2024 |
# Trades | 275 |
---|---|
Vol. Sold | 746,383 |
Sold Value | £240.17k |
Vol. Bought | 1,082,444 |
Bought Value | £337.21k |
PE Ratio | 194.70588 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 5.109% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 16:35:13 | 33.10 | 83,605 | Buy* | 32.95 | 33.85 | 27.67k | UT Uncrossing Trade |
03-May-24 | 16:29:52 | 33.30 | 262 | Buy* | 32.95 | 33.30 | 87.25 | A Automatic Execution |
03-May-24 | 16:29:50 | 33.20 | 2,026 | Buy* | 32.95 | 33.20 | 672.63 | A Automatic Execution |
03-May-24 | 16:29:40 | 33.00 | 15,968 | Sell* | 32.95 | 33.20 | 5,269 | O Ordinary |
03-May-24 | 16:28:54 | 33.00 | 230 | Sell* | 32.95 | 33.15 | 75.90 | O Ordinary |
03-May-24 | 16:27:33 | 32.95 | 5 | Sell* | 32.95 | 33.15 | 1.65 | O Ordinary Trade was executed as an SI |
03-May-24 | 16:27:17 | 33.126 | 41 | Buy* | 32.95 | 33.15 | 13.58 | O Ordinary |
03-May-24 | 16:26:41 | 33.001 | 5,000 | Sell* | 32.95 | 33.15 | 1,650 | O Ordinary |
03-May-24 | 16:25:44 | 33.00 | 50,000 | Sell* | 32.95 | 33.15 | 16.50k | O Ordinary |
03-May-24 | 16:24:59 | 32.95 | 5 | Sell* | 32.95 | 33.15 | 1.65 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions